Glenmede Trust’s Leonardo DRS DRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
$1.07M Buy
32,403
+72
+0.2% +$2.38K 0.01% 686
2024
Q4
$1.04M Sell
32,331
-1,629
-5% -$52.9K 0.01% 692
2024
Q3
$958K Buy
33,960
+435
+1% +$11.9K ﹤0.01% 730
2024
Q2
$855K Sell
33,525
-18,050
-35% -$413K ﹤0.01% 735
2024
Q1
$1.14M Sell
51,575
-756
-1% -$15.7K 0.01% 680
2023
Q4
$1.05M Buy
52,331
+19,381
+59% +$366K 0.01% 675
2023
Q3
$550K Buy
+32,950
New +$556K ﹤0.01% 816

Other funds holding DRS

Glenmede Trust's DRS Position: Q1 2025 in Review

Glenmede Trust increased its Leonardo DRS (DRS) stake by 0.22% in Q1 2025, buying an estimated $2.38K and bringing the position to 32,403 shares worth $1.07M. The position accounts for 0.01% of the portfolio, ranked #686.

Glenmede Trust first reported a position in DRS in Q3 2023 and has held it in 7 quarters since. The position peaked at $1.14M in Q1 2024. 254 funds tracked by Wall St. Rank hold DRS as of Q1 2025.

  • Glenmede Trust held 32,403 shares of Leonardo DRS worth $1.07M as of Q1 2025.
  • Glenmede Trust bought 72 Leonardo DRS shares in Q1 2025, an estimated $2.38K.
  • Leonardo DRS made up 0.01% of Glenmede Trust's portfolio in Q1 2025, its #686 holding.
  • Glenmede Trust first reported a position in Leonardo DRS in Q3 2023 and has held it in 7 quarters since.
  • Glenmede Trust's Leonardo DRS position peaked at $1.14M in Q1 2024.
  • 254 funds tracked by Wall St. Rank held Leonardo DRS as of Q1 2025.

Based on Glenmede Trust's 13F filing for Q1 2025, filed 15 May 2025.